NASDAQ: IIN |
| Healthcare / Medical Devices & Instruments / USA |
23.93 | -0.0200 | -0.08% | Vol 118.17K | 1Y Perf 6.78% |
May 13th, 2022 16:00 DELAYED |
BID | 23.88 | ASK | 23.94 | ||
Open | 24.03 | Previous Close | 23.95 | ||
Pre-Market | - | After-Market | - | ||
- -% | - - |
Target Price | 25.00 | Analyst Rating | Strong Buy 1.00 | |
Potential % | 4.47 | Finscreener Ranking | ★★★★+ 58.38 | |
Insiders Trans % 3/6/12 mo. | -/-/-100 | Value Ranking | ★★★★+ 60.54 | |
Insiders Value % 3/6/12 mo. | -/-/-100 | Growth Ranking | ★+ 43.54 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 84.19 | Earnings Rating | Strong Buy | |
Market Cap | 222.60M | Earnings Date | 9th May 2022 | |
Alpha | 0.02 | Standard Deviation | 0.19 | |
Beta | 1.00 |
Today's Price Range 23.9324.05 | 52W Range 12.4726.08 | 5 Year PE Ratio Range -44.50284.40 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Week | -0.33% | ||
1 Month | -0.13% | ||
3 Months | 44.85% | ||
6 Months | 14.94% | ||
1 Year | 6.78% | ||
3 Years | -4.43% | ||
5 Years | 176.65% | ||
10 Years | 254.52% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -1.82 | |||
ROE last 12 Months | -0.12 | |||
ROA (5Y Avg) | -1.07 | |||
ROA last 12 Months | -0.09 | |||
ROC (5Y Avg) | 2.26 | |||
ROC last 12 Months | -0.11 | |||
Return on invested Capital Q | 0.02 | |||
Return on invested Capital Y | 0.02 | |||
Assets Turnover | 0.80 | |||
Receivables Turnover | 5.00 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-1 200.50 | ||||
2.38 | ||||
2.38 | ||||
497.90 | ||||
-29.90 | ||||
0.05 | ||||
3.15 | ||||
10.09 | ||||
203.04M | ||||
Forward PE | 22.78 | |||
PEG | -99.83 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.20 | ||||
3.70 | ||||
0.04 | ||||
0.06 | ||||
4.40 | ||||
Leverage Ratio | 1.30 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
25.10 | ||||
0.40 | ||||
4.80 | ||||
0.50 | ||||
-0.76 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
93.44M | ||||
10.07 | ||||
-0.07 | ||||
10.05 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2022 | - | 0.24 | - |
Q04 2021 | 0.01 | 0.18 | 1.70K |
Q03 2021 | -0.08 | 0.12 | 250.00 |
Q02 2021 | 0.08 | 0.23 | 187.50 |
Q01 2021 | 0.00 | 0.26 | - |
Q04 2020 | 0.02 | 0.12 | 500.00 |
Q03 2020 | -0.05 | 0.07 | 240.00 |
Q02 2020 | -0.29 | -0.02 | 93.10 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
3/2022 QR | 0.06 | 0.00 | - |
6/2022 QR | 0.11 | 0.00 | - |
12/2022 FY | 0.47 | 20.51 | Positive |
12/2023 FY | 1.05 | 0.00 | - |
Next Report Date | - |
Estimated EPS Next Report | 0.06 |
Estimates Count | 1 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 118.17K |
Shares Outstanding | 9.30K |
Shares Float | 6.89M |
Trades Count | 1.42K |
Dollar Volume | 2.84M |
Avg. Volume | 100.82K |
Avg. Weekly Volume | 89.83K |
Avg. Monthly Volume | 79.13K |
Avg. Quarterly Volume | 133.50K |
IntriCon Corporation (NASDAQ: IIN) stock closed at 23.93 per share at the end of the most recent trading day (a -0.08% change compared to the prior day closing price) with a volume of 118.17K shares and market capitalization of 222.60M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 780 people. IntriCon Corporation CEO is Scott Longval.
The one-year performance of IntriCon Corporation stock is 6.78%, while year-to-date (YTD) performance is 47.99%. IIN stock has a five-year performance of 176.65%. Its 52-week range is between 12.47 and 26.0821, which gives IIN stock a 52-week price range ratio of 84.19%
IntriCon Corporation currently has a PE ratio of -1 200.50, a price-to-book (PB) ratio of 2.38, a price-to-sale (PS) ratio of 2.38, a price to cashflow ratio of 497.90, a PEG ratio of 2.32, a ROA of -0.09%, a ROC of -0.11% and a ROE of -0.12%. The company’s profit margin is -0.76%, its EBITDA margin is 4.80%, and its revenue ttm is $93.44 Million , which makes it $10.07 revenue per share.
Of the last four earnings reports from IntriCon Corporation, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.06 for the next earnings report. IntriCon Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for IntriCon Corporation is Strong Buy (1), with a target price of $25, which is +4.47% compared to the current price. The earnings rating for IntriCon Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
IntriCon Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
IntriCon Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 23.76, ATR14 : 0.26, CCI20 : 17.41, Chaikin Money Flow : -0.06, MACD : 0.12, Money Flow Index : 48.22, ROC : -0.25, RSI : 60.79, STOCH (14,3) : 90.00, STOCH RSI : 0.16, UO : 83.00, Williams %R : -10.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of IntriCon Corporation in the last 12-months were: Dennis L. Gonsior (Sold 0 shares of value $-93 900 ), Michael P. Geraci (Sold 0 shares of value $-149 100 ), Michael P. Geraci (Sold 12 235 shares of value $256 388 ), Scott Longval (Sold 0 shares of value $-187 800 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Moderate Buy | Strong Buy |
IntriCon Corp design, develop and manufacture miniature and micro-miniature body-worn medical and electronics products. The company has two operating segments, the Body-Worn Device segment (consisting of three markets: medical, hearing health, and professional audio), and the Hearing Health Direct-to-Consumer segment. Its primary geographic markets are the United States, Europe, Asia, and all other countries. The company serves a diverse range of markets including the hearing healthcare market, the medical biotelemetry market, and the professional audio communication market.
CEO: Scott Longval
Telephone: +1 651 636-9770
Address: 1260 Red Fox Road, Arden Hills 55112, MN, US
Number of employees: 780
Mon, 28 Feb 2022 18:25 GMT Colliers Securities Downgrades Intricon (IIN) to Hold
- TipRanks. All rights reserved.Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2022. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.